Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Financials are out on Sedar

<< Previous

Bullboard Posts

Next >>

Comment by socksnblonds642on Jul 20, 2021 9:36am

163 Views

Post# 33574512

RE:RE:Financials are out on Sedar

I don't think anything has changed news wise hence no change in the results. They can't make up CR numbers for a Q2 financial. We simply have to wait for the results.
Does it say how much money is left or how the trials are progressing etc? That would be interesting.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”